PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Demonstrates therapeutic advantages through modulation of immune pathways and intervention in HBV lifecycle targets [PMID:40708494]
Yinchenhao decoction (YCHD) is used to treat cholestasis and mitigate cholestatic liver injury [PMID:38583348, PMID:40732223]
Water extract alleviates MASLD by inhibiting miR-34a-5p [PMID:39515682]; Injinoryeong-san (containing A. capillaris) attenuates MASH via YAP/TAZ-signaling [PMID:40683423]
Yin-Chen-Hao-Tang (YCHT) alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation [PMID:25829784]
Water extract attenuates adriamycin-induced renal injury by regulating apoptosis through the ROS/MAPK axis [PMID:34984698]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 28275293 (2017) — Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases. · World journal of gastroenterology
- 2.PMID: 40708494 (2025) — The Role of Chinese Medicine in the Treatment of Chronic Hepatitis B. · The American journal of Chinese medicine
- 3.PMID: 40553824 (2025) — Investigating therapeutic effects and the underlying mechanisms of jia-wei-yin-chen-hao-tang in non-alcoholic fatty liver disease based on network pharmacology analysis and experimental validation. · Journal of ethnopharmacology
- 4.PMID: 24716150 (2013) — Recent Studies and Progression of Yin Chen Hao ( Yīn Chén Hāo), a Long-term Used Traditional Chinese Medicine. · Journal of traditional and complementary medicine
- 5.PMID: 34680529